On April 27, 2020, the King George Medical University in Uttar Pradesh became the first government hospital to launch plasma therapy to treat COVID-19. The first dose of plasma therapy was given to a 58-year old patient.
Highlights
- The Drug Controller General of India (DGCI) recently cleared the proposal of plasma therapy that was submitted by ICMR.
- The DGCI nodded to use plasma from recovered COVID-19 patients.
What is the process?
- The patients recovered from COVID-19 generate IGM and IGG antibodies against the virus.
- These antibodies are assessed from the samples of the donors through rapid tests.
- The plasma collected from the volunteering donors are then transfused into patients that are critically sick due to the virus.
- The DGCI has passed an order that not more than 1000 ml of plasma can be collected from a donor in one month.
Current Scenario
- The states and union territories such as Delhi, Maharashtra, Uttar Pradesh have begun to use plasma therapy treatment.
- However, King George Medical University is the first to use the treatment in government hospital.
History of the therapy in India
- In India, the plasma therapy had been used to treat diseases such as mumps, measles, polio and flu.
- The treatment was used before vaccines were available.
- Plasma therapy was used to heal 1703 patients of Spanish flu in 1918.
No comments:
Post a Comment